Page 7 - ஆராய்ச்சி இணைந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆராய்ச்சி இணைந்து. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆராய்ச்சி இணைந்து Today - Breaking & Trending Today

RubrYc Therapeutics Announces a Research Collaboration and License Option Agreement With Zai Labs


Search jobs
RubrYc Therapeutics Announces a Research Collaboration and License Option Agreement With Zai Labs
SAN CARLOS, Calif. (BUSINESS WIRE) RubrYc Therapeutics, Inc., a pre-clinical biotherapeutics company developing epitope selective therapies, today announced that it has entered into a research collaboration and license option agreement with Zai Labs, Inc. for the use of RubrYc’s Meso-scale Engineered Molecules (MEMs) platform, to identify monoclonal antibodies with enhanced biological function for an undisclosed oncology target.
Under the terms of the agreement RubrYc and Zai Labs will collaborate to identify product candidates using RubrYc’s Discovery Engine, which leverages machine learning and structural data to identify antibodies that bind to subdominant epitopes and exhibit differentiated activity. Upon exercise of the license option Zai Labs would have exclusive global rights to develop and commercialize product(s) of the Re ....

United States , San Carlos , Healthtell Inc , Hayan Health Networks , Zai Lab , Paladin Capital Group , Zai Labs Inc , Rubryc Therapeutics Inc , Research Collaboration , Rubryc Therapeutics , Zai Labs , Meso Scale Engineered Molecules , Discovery Engine , Isaac Bright , Rubryc Discovery Engine , Third Point Ventures , Vital Venture Capital , Hayan Health , ஒன்றுபட்டது மாநிலங்களில் , சான் கார்லோஸ் , ஹயான் ஆரோக்கியம் நெட்வொர்க்குகள் , ஜா ஆய்வகம் , ப்யாலடிந் மூலதனம் குழு , ஆராய்ச்சி இணைந்து , ஜா ஆய்வகங்கள் , கண்டுபிடிப்பு இயந்திரம் ,

CSIR-CMERI- Stepping towards a Shining North-East


Apr 12, 2021
Shri M.S. Rao, IAS, Chief Secretary of Meghalaya, visited the CSIR-CMERI exhibit & expressed a lot of interest in the CSIR-CMERITechnologies especially the Ginger-Turmeric Processing unit, Solar-based Hybrid Mini-Grid& municipal waste management. Shri Rao showed his interest to explore avenues for roping in CSIR-CMERI technologies for empowering Meghalaya and making it Sustainable. Shri Sanjib Dhar, Joint Secretary, Ri-Bhoi Farmers Union, Meghalaya shared their enthusiasm and amazement at the CSIR-CMERI Ginger-Turmeric Processing Technologies. They expressed their intent to visit CSIR-CMERI, Durgapur to understand more about the Sustainable Ecological Concepts and Farming Technological Advancements of CSIR-CMERI and help disseminate the same amongst the farming community of Meghalaya. Director, National Institute of Technology, Meghalaya and his teamdiscussed with officials of CSIR-CMERI for exploring opportunities for an MoU signing regarding Implementation of CS ....

West Bengal , New Delhi , Atanu Saha , Shri Sanjib Dhar , Shri Rao , Shrims Rao , National Institute Of Technology , Bhoi Farmers Union , Research Collaboration , Technology Intervention , Centre For Technology Application , Skill Development , Convention Centre , North East Council , Transforming Meghalaya State , North East Centre , Technology Application , Estate Convention Centre , Ginger Turmeric Processing Technologies , Municipal Solid Waste Management , Solar Tree , Complete Water Purification Technologies , Effluent Treatment Plant , Hybrid Mini Grid , Chief Secretary , Ginger Turmeric Processing ,

Research shows end of life care was not seen as an essential, frontline service in pandemic


Date Time
Share
King’s College London
Findings from a new report prompt calls for proper recognition and sustainable funding of end of life care and bereavement support.
A new report published today shows how palliative and end of life care in the UK was compromised by shortages of PPE, essential medicines, and equipment, because these services were not seen as ‘frontline NHS’ in the pandemic.
Better End of Life – a collaboration between Marie Curie, King’s College London Cicely Saunders Institute, Hull York Medical School, University of Hull, and the University of Cambridge – is a new research programme that will examine evidence on the current state of dying, death and bereavement across the four nations of the UK and propose a policy agenda aimed at helping to ensure that everyone has the best possible end of life experience. ....

United Kingdom , City Of , Marie Curie , Katherine Sleeman , Georg Arthur Pflueger , Stephen Barclay , Matthew Reed , Fliss Murtagh , King College London , Cicely Saunders Institute , Wolfson Palliative Care Centre , University Of Cambridge , Hull York Medical School , United Kingdom Research , King College London Cicely Saunders Institute , King College Hospital , University Of Hull , Community Nurses , Expert Group , Reference Group , Research Collaboration , National Institute For Health Research , Department Of Public Health , Cicely Saunders International , College London Cicely Saunders Institute , Professor Katherine Sleeman ,

4D pharma : Annual Report (SEC Filing - 20-F)



Not for trading, but in connection with the registration of American Depositary Shares, pursuant to the requirements of the Securities and Exchange Commission.
Securities registered or to be registered pursuant to Section 12(g) of the Act:
None
None
Indicate the number of outstanding shares of each of the issuer s classes of capital or common stock as of the close of the period covered by the annual report:
Title of each class
Ordinary Shares, nominal value £0.0025 per
Share
131,467,935
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Yes [ ] No [X] ....

United States , Hong Kong , District Of Columbia , United Kingdom , State Of New York , New York , New Zealand , British Virgin Islands , South Korea , South Africa , Palm Beach Gardens , University Of San Diego , United Arab Emirates , Northern Ireland , Nordrhein Westfalen , City Of , Saudi Arabia , Duncan Peyton , D Pharma Le , John Beck , Antonio Fernandez , Merck Kga , Edgardo Baracchini , Ardea Biosciences , Merck Serono , Sandy Macrae ,